ADJUVANT THERAPY
Clinical trials for ADJUVANT THERAPY explained in plain language.
Never miss a new study
Get alerted when new ADJUVANT THERAPY trials appear
Sign up with your email to follow new studies for ADJUVANT THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental 'Armored' cell shot targets solid cancers in tiny safety trial
Disease control Recruiting nowThis early study is testing a single injection of special immune cells (dendritic cells) that are 'armored' with antibodies to see if they are safe for people with solid tumors like pancreatic, colorectal, or stomach cancer. Only 8 adults who have already had surgery and chemothe…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
New combo therapy aims to stop high-risk breast cancer recurrence
Disease control Recruiting nowThis study tests whether adding a CDK4/6 inhibitor to standard hormone therapy can help prevent breast cancer from returning in women with a high-risk type called HR+/HER2+ early breast cancer. About 1,900 women who have already completed anti-HER2 treatment will be randomly assi…
Matched conditions: ADJUVANT THERAPY
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
Sitting less during cancer treatment could boost Well-Being, new study tests digital solution
Symptom relief Recruiting nowThis study tests whether a digital support program can help people with breast, prostate, or colorectal cancer reduce the time they spend sitting during their treatment. The goal is to improve their well-being and lower future health risks. The study will involve 172 participants…
Matched conditions: ADJUVANT THERAPY
Phase: NA • Sponsor: Mälardalen University • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Real-World study tracks breast cancer relapses after targeted therapy
Knowledge-focused Recruiting nowThis study follows 750 women and men with a common type of breast cancer who were treated with CDK4/6 inhibitors after surgery. Researchers want to learn more about the characteristics and outcomes of those whose cancer returns. The goal is to gather real-world data to better und…
Matched conditions: ADJUVANT THERAPY
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC